# MITIGO
> **ANDA204393** · Abbreviated New Drug Application (Generic) · Sponsor: PIRAMAL CRITICAL · Approved 2018-07-16
## Drug
- **FDA Application Number:** ANDA204393
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MITIGO
- **Generic name:** MORPHINE SULFATE
- **Active ingredients:** MORPHINE SULFATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** PIRAMAL CRITICAL
- **Manufacturer:** Piramal Critical Care, Inc.
- **First approval:** 2018-07-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204393)
---
*AI Analytics · CC0 1.0*